GLP-1 drugs are forcing companies to adapt to a sustained shift in consumer behavior and healthcare demand that touches both food and pharma supply chains.
The tool is meant to serve as a starting point rather than a final judgment, by offering an early warning of potential forced labor risks based on publicly available data.
Leaders must move beyond the notion of agentic AI as merely a technical tool, and recognize its capacity to drive tangible improvements across sourcing, procurement and contracting processes.
Amazon has seen tariffs "creep into prices" for sellers, who have been left to decide between passing increased costs onto customers, or absorbing the costs to drive demand.
CPOs will gain more recognition and influence, with growing responsibility for supply chain resilience, AI adoption and long-term business performance, predicts supply chain and procurement consulting firm Inverto.
Companies that adopt verifiable data frameworks will achieve coordination faster, operate with greater resilience, and reduce the friction that currently consumes operational budgets.